Lipoprotein (a) testing patterns among subjects with a measured lipid panel: The Mayo Clinic experience

Objective: Lipoprotein(a) [Lp(a)] has been associated with Atherosclerotic Cardiovascular Disease (ASCVD). Approximately 20 % of the population has elevated Lp(a). Despite its well-recognized role in ASCVD, universal screening remains controversial. The aim of our study is to investigate laboratory...

Full description

Bibliographic Details

Published in:	American Journal of Preventive Cardiology
Main Authors:	Matteo Manzato, Jeffery W. Meeusen, Leslie J. Donato, Allan S. Jaffe, Vlad C. Vasile
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Subjects:	Lipoprotein (a) Atherosclerosis Risk Evaluation and Mitigation Prevention Primary
Online Access:	http://www.sciencedirect.com/science/article/pii/S266666772400254X